# Journal Of Clinical Endocrinology And Metabolism > Use when targeting the Journal of Clinical Endocrinology and Metabolism or deciding whether a clinical-endocrinology or metabolism study fits this venue. Encodes the journal's broad endocrine-organ fit, the clinical-evidence and methodological bar, reporting-guideline and registration requirements, Endocrine Society/OUP house style, official-submission re-check, and desk-reject heuristics. Venue-fit aid only, not clinical advice. - Skill: `thedixitjain/journal-of-clinical-endocrinology-and-metabolism` (Agent Skill) - Install (CLI): `npx skillmds add thedixitjain/journal-of-clinical-endocrinology-and-metabolism` - Raw SKILL.md: https://api.skillmd.com/api/skills/thedixitjain/journal-of-clinical-endocrinology-and-metabolism/raw - Safety review: pending - Works with: Claude Code, Claude.ai, OpenAI Codex - Category: Research & Search - Author: thedixitjain (https://skillmd.com/u/thedixitjain) - Updated: 2026-09-09 - Page: https://skillmd.com/skills/thedixitjain/journal-of-clinical-endocrinology-and-metabolism --- # Journal of Clinical Endocrinology and Metabolism (journal-of-clinical-endocrinology-and-metabolism) ## Journal positioning The Journal of Clinical Endocrinology and Metabolism (JCEM, Endocrine Society / Oxford University Press) is the Endocrine Society's flagship clinical journal, publishing research across the **full breadth of clinical endocrinology and metabolism** — thyroid, adrenal, pituitary/neuroendocrine, bone and mineral, reproductive endocrinology, obesity, lipid, and diabetes/metabolism — with an emphasis on human, patient-oriented studies that inform endocrine diagnosis and management. Its defining expectation is a **clinically important advance in the diagnosis, treatment, or pathophysiology of an endocrine or metabolic disorder in humans**, not a narrow single-center series, a pure animal study with no human translation, or a diabetes-only paper better placed in a dedicated diabetes journal. Breadth across endocrine organs is a feature: JCEM is the generalist endocrine venue. This skill is a **fit / venue-selection / re-framing** aid; it is not clinical or regulatory advice and does not replace the journal's current instructions for authors. Before submitting, re-check the live JCEM author instructions. ## When to trigger - The author names JCEM for a clinical-endocrinology or metabolism study across any endocrine organ system and wants a fit/framing check. - An endocrine study must be re-framed around a patient-oriented diagnostic, therapeutic, or pathophysiologic question. - The author is choosing between JCEM (broad endocrine), Diabetologia (diabetes-specific), and The Lancet Diabetes & Endocrinology (high-impact trials). - The author needs the journal's reporting-guideline, registration, and human-endocrine-study expectations. ## Scope & topic fit - Thyroid, adrenal, and pituitary/neuroendocrine disorders: diagnosis, hormone assays, and management studies. - Bone, mineral, and calcium metabolism: osteoporosis, parathyroid, and vitamin-D endocrinology. - Reproductive and developmental endocrinology: PCOS, hypogonadism, fertility, and pubertal/growth disorders. - Obesity, lipid, and energy metabolism with endocrine mechanism or clinical management endpoints. - Diabetes and glucose metabolism as part of broad endocrine practice (with awareness of diabetes-dedicated venues). - Endocrine clinical trials, cohorts, biomarker/hormone-assay validation, and pharmacologic/hormone-therapy studies in humans. ## Method & evidence bar - Studies must be adequately powered with prespecified, patient-centered endocrine endpoints; surrogate hormone endpoints need clinical justification. - The applicable reporting guideline and checklist are expected: CONSORT for trials, STROBE for observational work, PRISMA for systematic reviews, STARD for diagnostic/assay accuracy. - Trials require prospective registration and the registration number; protocol/SAP are expected. - Hormone assays and biomarker methods must be validated and described (platform, reference intervals, harmonization); analytic rigor is scrutinized. - Observational claims must address confounding, bias, and missing data; causal language must match the design. - Effect estimates need confidence intervals and absolute as well as relative measures; clinical significance must be argued. ## Structure & house style - Endocrine Society/OUP format with a structured abstract and a precis/context-and-significance statement; re-check current article types (Clinical Research Article, etc.) and limits on the live guide. - The introduction frames the endocrine clinical question; the discussion states the diagnostic or management implication plainly. - A CONSORT/STROBE/PRISMA/STARD flow diagram is expected for the relevant design. - Tables/figures follow the journal's statistical-reporting standards; a supplement carries the protocol, full assay/statistical methods, and additional analyses. ## Official-submission checklist - Before giving submission-ready advice, read `../../resources/source-basis.md` and `../../resources/official-source-map.md`; start from the ICMJE/EQUATOR and Endocrine Society/OUP anchors, then cite the current JCEM page you checked. - Search the live site for "JCEM Endocrine Society instructions for authors" and follow the current version. - Re-check article types, abstract and precis format, and word/figure/reference limits. - Confirm trial registration, the reporting checklist (CONSORT/STROBE/PRISMA/STARD), assay-validation reporting, data/code-availability, and protocol/SAP submission. - Re-check IRB/ethics and consent, ICMJE authorship and conflict-of-interest disclosure, funding, and AI-use disclosure. - If the live official instructions conflict with this skill, the official instructions win. ## Pre-submission self-check - [ ] The study answers a patient-oriented endocrine diagnostic, therapeutic, or pathophysiologic question. - [ ] Endocrine endpoints are prespecified and powered; trials are registered with the number in the manuscript. - [ ] The correct reporting checklist (CONSORT/STROBE/PRISMA/STARD) is completed and attached. - [ ] Hormone assays/biomarkers are validated and fully described. - [ ] Confounding, bias, and missing data are addressed; causal language matches the design. - [ ] IRB/consent, ICMJE disclosures, and a data-availability statement are prepared. ## Common desk-reject triggers - Single-center descriptive series with limited generalizability and no clear management change. - Pure animal/cell endocrine studies with no human translation or clinical relevance. - Unvalidated or poorly described hormone assays underpinning the main claim. - Missing trial registration, protocol, or the required reporting checklist. - Diabetes-only or single-trial work better placed in a dedicated diabetes or high-impact venue. ## Re-routing decision - Diabetes-focused clinical/epidemiologic or basic study → `diabetologia`. - High-impact diabetes/endocrine trial with broad reach → `the-lancet-diabetes-and-endocrinology`. - Diabetic kidney disease centered on nephrology → `journal-of-the-american-society-of-nephrology` / `kidney-international`. - Endocrine surgery (thyroid/adrenal/pituitary surgical outcomes) → `jama-surgery`. - Broad practice-changing endocrine trial → general medicine (`jama` / NEJM / The Lancet in the natural-science bundle). ## Output format ```text [Fit] High / Medium / Low (one-line reason) [Target] Journal of Clinical Endocrinology and Metabolism (Endocrine Society/OUP) [Specialty tags] [Study design / reporting guideline] [Method/evidence] [Top risk] [Official items to re-check]
[Re-route suggestion] ``` --- **Source:** [`brycewang-stanford/Awesome-Journal-Skills`](https://github.com/brycewang-stanford/Awesome-Journal-Skills) → `Clinical-Medicine-Journal-Skills/skills/journal-of-clinical-endocrinology-and-metabolism/SKILL.md`